Table 1.

Summary of Current Limitations to the Clinical Utility of Advanced Lipoprotein Tests

Lack of standardization and comparability of information provided by various tests

Information overload can be minimized by focusing on several key lipoprotein measures

Accessibility

Demonstration that tests alter clinical management of patients, such as improving risk classification or targeting of therapy

Identifying subgroups of individuals who may particularly benefit from testing (e.g. those with cardiometabolic risk factors)

Evaluation of cost-benefit ratio